DK162604C - Fremgangsmaade til fremstilling af humant immuninterferon samt farmaceutiske praeparater indeholdende immuninterferon fremstillet ved fremgangsmaaden ifoelge opfindelsen og anvendelse af humant interferon fremstillet ved fremgangsmaaden ifoelge opfindelsen til fremstilling af et terapeutisk middel - Google Patents

Fremgangsmaade til fremstilling af humant immuninterferon samt farmaceutiske praeparater indeholdende immuninterferon fremstillet ved fremgangsmaaden ifoelge opfindelsen og anvendelse af humant interferon fremstillet ved fremgangsmaaden ifoelge opfindelsen til fremstilling af et terapeutisk middel

Info

Publication number: DK162604C
Authority: DK; Denmark
Prior art keywords: purification; interferon; extraction; immune interferon; human immune
Prior art date: 1983-09-20

Application number

DK447784A

Other languages

Danish (da)

English (en)

Other versions

DK447784D0 (da

DK162604B (da

DK447784A (da

Inventor

Susumu Honda

Hsiang-Fu Kung

Hiromu Sugino

Original Assignee

Hoffmann La Roche

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1983-09-20

Filing date

1984-09-19

Publication date

1992-05-11

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24128473&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK162604(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1984-09-19 Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche

1984-09-19 Publication of DK447784D0 publication Critical patent/DK447784D0/da

1985-03-21 Publication of DK447784A publication Critical patent/DK447784A/da

1991-11-18 Publication of DK162604B publication Critical patent/DK162604B/da

1992-05-11 Application granted granted Critical

1992-05-11 Publication of DK162604C publication Critical patent/DK162604C/da

Links

238000000746 purification Methods 0.000 abstract 3
101000599940 Homo sapiens Interferon gamma Proteins 0.000 abstract 2
238000000605 extraction Methods 0.000 abstract 2
238000000034 method Methods 0.000 abstract 2
108010074328 Interferon-gamma Proteins 0.000 abstract 1
102000008070 Interferon-gamma Human genes 0.000 abstract 1
108010050904 Interferons Proteins 0.000 abstract 1
102000014150 Interferons Human genes 0.000 abstract 1
229940124158 Protease/peptidase inhibitor Drugs 0.000 abstract 1
229960004198 guanidine Drugs 0.000 abstract 1
PJJJBBJSCAKJQF-UHFFFAOYSA-N guanidinium chloride Chemical compound [Cl-].NC(N)=[NH2+] PJJJBBJSCAKJQF-UHFFFAOYSA-N 0.000 abstract 1
229940079322 interferon Drugs 0.000 abstract 1
244000005700 microbiome Species 0.000 abstract 1
239000000137 peptide hydrolase inhibitor Substances 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
- C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
- C07K1/1136—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by reversible modification of the secondary, tertiary or quarternary structure, e.g. using denaturating or stabilising agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/57—IFN-gamma
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Animal Behavior & Ethology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Zoology (AREA)
Molecular Biology (AREA)
Bioinformatics & Cheminformatics (AREA)
Wood Science & Technology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
General Engineering & Computer Science (AREA)
Biotechnology (AREA)
Biomedical Technology (AREA)
Plant Pathology (AREA)
Microbiology (AREA)
Communicable Diseases (AREA)
Gastroenterology & Hepatology (AREA)
Physics & Mathematics (AREA)
Oncology (AREA)
Crystallography & Structural Chemistry (AREA)
Immunology (AREA)
Analytical Chemistry (AREA)
Toxicology (AREA)
Virology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Saccharide Compounds (AREA)

DK447784A 1983-09-20 1984-09-19 Fremgangsmaade til fremstilling af humant immuninterferon samt farmaceutiske praeparater indeholdende immuninterferon fremstillet ved fremgangsmaaden ifoelge opfindelsen og anvendelse af humant interferon fremstillet ved fremgangsmaaden ifoelge opfindelsen til fremstilling af et terapeutisk middel DK162604C (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US53404083A	1983-09-20	1983-09-20
US53404083		1983-09-20

Publications (4)

Publication Number	Publication Date
DK447784D0 DK447784D0 (da)	1984-09-19
DK447784A DK447784A (da)	1985-03-21
DK162604B DK162604B (da)	1991-11-18
DK162604C true DK162604C (da)	1992-05-11

Family

ID=24128473

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK447784A DK162604C (da)	1983-09-20	1984-09-19	Fremgangsmaade til fremstilling af humant immuninterferon samt farmaceutiske praeparater indeholdende immuninterferon fremstillet ved fremgangsmaaden ifoelge opfindelsen og anvendelse af humant interferon fremstillet ved fremgangsmaaden ifoelge opfindelsen til fremstilling af et terapeutisk middel

Country Status (19)

Country	Link
EP (1)	EP0138087B1 (de)
JP (1)	JP2592441B2 (de)
KR (1)	KR940004544B1 (de)
AT (1)	ATE33842T1 (de)
AU (1)	AU590712B2 (de)
DE (1)	DE3470747D1 (de)
DK (1)	DK162604C (de)
ES (1)	ES8606886A1 (de)
FI (1)	FI80293C (de)
GB (1)	GB2146998B (de)
GR (1)	GR80405B (de)
HU (1)	HU196461B (de)
IL (1)	IL72986A (de)
MC (1)	MC1627A1 (de)
NO (1)	NO161274C (de)
NZ (1)	NZ209588A (de)
PH (1)	PH23241A (de)
PT (1)	PT79232B (de)
ZA (1)	ZA846554B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB2164650A (en) *	1984-09-25	1986-03-26	Fujisawa Pharmaceutical Co	Process for production of y-interferon
GB8508340D0 (en) *	1985-03-29	1985-05-09	Creighton T E	Production of protein
DE19755960C1 (de)	1997-12-16	1998-11-26	Hoechst Ag	Verfahren zum Aufschluß von biologischem Material

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NL7404589A (nl) *	1974-04-03	1975-10-07	Stichting Rega V Z W	Werkwijze voor het stabiliseren van interferon.
DE3005897A1 (de) *	1980-02-16	1981-09-03	Hoechst Ag, 6000 Frankfurt	Genprodukt eines hoeheren organismus aus einem dieses gen enhtaltenden mikroorganismus
IL65475A0 (en) *	1981-04-17	1982-07-30	Meloy Lab	Production of immune interferon and its mrna
IL63327A (en) *	1981-07-16	1985-11-29	Yeda Res & Dev	Production of interferon beta1 and alpha-phage recombinants for its production in host bacteria
AU561343B2 (en) *	1981-10-19	1987-05-07	Genentech Inc.	Human immune interferon by recombinant dna
JPS58110548A (ja) *	1981-12-24	1983-07-01	Asahi Chem Ind Co Ltd	新規な生理活性ペプチド
EP0088540A3 (de) *	1982-02-22	1984-10-17	Biogen, Inc.	DNS-Sequenzen, Rekombinante DNS-Moleküle und Verfahren zur Herstellung von dem immunen menschlichen Interferon ähnlichen Polypeptiden
IL68100A0 (en) *	1982-03-24	1983-06-15	Takeda Chemical Industries Ltd	Novel dna and use thereof
IL69851A0 (en) *	1982-09-30	1983-12-30	Japan Found Cancer	Novel dna and recombinant plasmid containing the same
WO1984002129A1 (fr) *	1982-11-22	1984-06-07	Takeda Chemical Industries Ltd	Proteine de l'interferon immun humain et son procede de preparation
JPH0740925B2 (ja) *	1983-03-14	1995-05-10	協和醗酵工業株式会社	新規ヒトインタ−フエロン−γポリペプチド
US4855238A (en) *	1983-12-16	1989-08-08	Genentech, Inc.	Recombinant gamma interferons having enhanced stability and methods therefor

1984
- 1984-08-22 ZA ZA846554A patent/ZA846554B/xx unknown
- 1984-09-18 AT AT84111130T patent/ATE33842T1/de not_active IP Right Cessation
- 1984-09-18 DE DE8484111130T patent/DE3470747D1/de not_active Expired
- 1984-09-18 NZ NZ209588A patent/NZ209588A/xx unknown
- 1984-09-18 IL IL72986A patent/IL72986A/xx not_active IP Right Cessation
- 1984-09-18 EP EP19840111130 patent/EP0138087B1/de not_active Expired
- 1984-09-18 GR GR80405A patent/GR80405B/el unknown
- 1984-09-19 PH PH31245A patent/PH23241A/en unknown
- 1984-09-19 NO NO843750A patent/NO161274C/no unknown
- 1984-09-19 KR KR84005714A patent/KR940004544B1/ko not_active Expired - Lifetime
- 1984-09-19 GB GB08423748A patent/GB2146998B/en not_active Expired
- 1984-09-19 JP JP59196499A patent/JP2592441B2/ja not_active Expired - Lifetime
- 1984-09-19 HU HU843509A patent/HU196461B/hu not_active IP Right Cessation
- 1984-09-19 PT PT79232A patent/PT79232B/pt not_active IP Right Cessation
- 1984-09-19 DK DK447784A patent/DK162604C/da not_active IP Right Cessation
- 1984-09-19 AU AU33301/84A patent/AU590712B2/en not_active Ceased
- 1984-09-19 MC MC841728A patent/MC1627A1/fr unknown
- 1984-09-19 FI FI843669A patent/FI80293C/fi not_active IP Right Cessation
- 1984-09-19 ES ES536028A patent/ES8606886A1/es not_active Expired

Also Published As

Publication number	Publication date
FI843669A0 (fi)	1984-09-19
KR940004544B1 (en)	1994-05-25
DK447784D0 (da)	1984-09-19
NO843750L (no)	1985-03-21
DK162604B (da)	1991-11-18
FI80293C (fi)	1990-05-10
JP2592441B2 (ja)	1997-03-19
HU196461B (en)	1988-11-28
IL72986A0 (en)	1984-12-31
AU3330184A (en)	1985-03-28
PT79232B (en)	1986-11-18
NZ209588A (en)	1989-05-29
EP0138087A1 (de)	1985-04-24
MC1627A1 (fr)	1985-09-26
FI843669L (fi)	1985-03-21
NO161274B (no)	1989-04-17
PH23241A (en)	1989-06-06
KR850002285A (ko)	1985-05-10
ES8606886A1 (es)	1986-05-16
EP0138087B1 (de)	1988-04-27
GB2146998B (en)	1987-10-07
ATE33842T1 (de)	1988-05-15
HUT35289A (en)	1985-06-28
FI80293B (fi)	1990-01-31
IL72986A (en)	1990-04-29
PT79232A (en)	1984-10-01
AU590712B2 (en)	1989-11-16
ZA846554B (en)	1985-04-24
GR80405B (en)	1985-01-21
ES536028A0 (es)	1986-05-16
GB2146998A (en)	1985-05-01
GB8423748D0 (en)	1984-10-24
NO161274C (no)	1989-07-26
DE3470747D1 (en)	1988-06-01
DK447784A (da)	1985-03-21
JPS6169800A (ja)	1986-04-10

Legal Events

Date	Code	Title	Description
1998-05-11	PBP	Patent lapsed

Publication	Publication Date	Title
DK0663010T3 (da)	2000-11-13	Fremgangsmåde til forøgelse af sekretion af overudtrykte proteiner
KR950700779A (ko)	1995-02-20	단백질의 정제방법(Protein purification)
DK0620854T3 (da)	1999-06-14	Ekspression og oprensning af rekombinant opløselig vævsfaktor
ATE162079T1 (de)	1998-01-15	Verwendung von antikörper enthaltenden präparationen zur immunsuppression
DK430486D0 (da)	1986-09-09	Fremgangsmaade til udvinding af protein
DK447584D0 (da)	1984-09-19	Fremgangsmaade til rensning af immuninterferon
DE69028513D1 (de)	1996-10-17	Träger zur bindung von antiphospholipid-antikörpern, diese antikörper verwendender immunotest und kit dafür
DK516485D0 (da)	1985-11-08	Fremgangsmaade til spaltning af peptider og proteiner ved methionyl-bindingen
DE68913251D1 (de)	1994-03-31	Verfahren zur Verringerung der Heterogenität von monoklonalen Antikörpern.
ES8505406A1 (es)	1985-06-01	Procedimiento de obtener y aislar hibridomas secretores de anticuerpos, procedimiento de obtener anticuerpos y metodo de obtener polipeptidos
DE3853481D1 (de)	1995-05-04	Fv Antikörperfragment-Herstellung.
DK162604C (da)	1992-05-11	Fremgangsmaade til fremstilling af humant immuninterferon samt farmaceutiske praeparater indeholdende immuninterferon fremstillet ved fremgangsmaaden ifoelge opfindelsen og anvendelse af humant interferon fremstillet ved fremgangsmaaden ifoelge opfindelsen til fremstilling af et terapeutisk middel
NO874107L (no)	1988-04-05	Nye monoklonale antistoffer mot ifn-waa, fremgangsmaate til fremstilling derav og anvendelse for rensing samt paavisning av ifn-omega.
DK0401657T3 (da)	1994-03-21	Fremgangsmåde til C-terminal modificering af proteiner
IT1178489B (it)	1987-09-09	Vettore clonante, procedimento per la sua costruzione e procedimento di concentrazione e di purificazione di proteine prodotte, formate dal vettore clonante